Literature DB >> 7439255

The radioimmunoassay of buprenorphine.

A J Bartlett, J G Lloyd-Jones, M J Rance, I R Flockhart, G J Dockray, M R Bennett, R A Moore.   

Abstract

Antisera to buprenorphine were obtained in rabbits immunised with 3-0-carboxymethylbuprenorphine and N-hemisuccinyl-norbuprenorphine conjugated to bovine serum albumin. Using the latter antiserum and tritium labelled buprenorphine a radioimmunoassay have good accuracy and precision was developed for concentrations as low as 50 picograms in 1 ml of plasma. The N-hemisuccinyl antiserum crossreacted with norbuprenorphine, and the 3-0-glucuronide conjugate with the 3-0-carboxymethyl antiserum. Cross-reactivity of both antisera to other pharmacologically related compounds was negligible. The assay was employed to determine plasma buprenorphine concentration following its parenteral administration to dog and man.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7439255     DOI: 10.1007/bf00561392

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  9 in total

1.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

2.  Human pharmacology and abuse potential of the analgesic buprenorphine: a potential agent for treating narcotic addiction.

Authors:  D R Jasinski; J S Pevnick; J D Griffith
Journal:  Arch Gen Psychiatry       Date:  1978-04

3.  A double-blind comparison of morphine and buprenorphine in the prevention of pain after operation.

Authors:  B Kay
Journal:  Br J Anaesth       Date:  1978-06       Impact factor: 9.166

Review 4.  Radioimmunoassay.

Authors:  D S Skelley; L P Brown; P K Besch
Journal:  Clin Chem       Date:  1973-02       Impact factor: 8.327

5.  Quantitative determination of morphine in serum by radioimmunoassay.

Authors:  S Spector
Journal:  J Pharmacol Exp Ther       Date:  1971-08       Impact factor: 4.030

6.  Actions of etorphine hydrochloride, (M99): a potent morphine-like agent.

Authors:  G F Blane; A L Boura; A E Fitzgerald; R E Lister
Journal:  Br J Pharmacol Chemother       Date:  1967-05

7.  A sensitive radioimmunoassay for fentanyl. Plasma level in dogs and man.

Authors:  M Michiels; R Hendriks; J Heykants
Journal:  Eur J Clin Pharmacol       Date:  1977-10-14       Impact factor: 2.953

8.  Morphine: radioimmunoassay.

Authors:  S Spector; C W Parker
Journal:  Science       Date:  1970-06-12       Impact factor: 47.728

9.  Morphine-3-succinyl--bovine serum albumin: an immunogenic hapten-protein conjugate.

Authors:  B H Wainer; F W Fitch; R M Rothberg; J Fried
Journal:  Science       Date:  1972-06-09       Impact factor: 47.728

  9 in total
  10 in total

Review 1.  Buprenorphine: clinical pharmacokinetics in the treatment of opioid dependence.

Authors:  Alexander Elkader; Beth Sproule
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 6.447

2.  Enzyme immunoassay of buprenorphine.

Authors:  G K Tiong; J E Olley
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-08       Impact factor: 3.000

3.  Effects of epidural buprenorphine on bowel movement following gynecological surgery.

Authors:  Yoshitaka Toyoda; Hiroshi Morisaki; Tomoko Yorozu; Toshiyuki Shigematsu
Journal:  J Anesth       Date:  1995-06       Impact factor: 2.078

Review 4.  Clinical pharmacokinetics of narcotic agonist-antagonist drugs.

Authors:  R E Bullingham; H J McQuay; R A Moore
Journal:  Clin Pharmacokinet       Date:  1983 Jul-Aug       Impact factor: 6.447

5.  Sublingual buprenorphine used postoperatively: ten hour plasma drug concentration analysis.

Authors:  R E Bullingham; H J McQuay; E J Porter; M C Allen; R A Moore
Journal:  Br J Clin Pharmacol       Date:  1982-05       Impact factor: 4.335

6.  Polystyrene-Core, Silica-Shell Scintillant Nanoparticles for Low-Energy Radionuclide Quantification in Aqueous Media.

Authors:  Colleen M Janczak; Isen A C Calderon; Zeinab Mokhtari; Craig A Aspinwall
Journal:  ACS Appl Mater Interfaces       Date:  2018-01-24       Impact factor: 9.229

7.  Investigation of the antinociceptive activity of buprenorphine in sheep.

Authors:  A Nolan; A Livingston; A E Waterman
Journal:  Br J Pharmacol       Date:  1987-11       Impact factor: 8.739

8.  Pharmacokinetics of intravenous buprenorphine in children.

Authors:  K T Olkkola; E L Maunuksela; R Korpela
Journal:  Br J Clin Pharmacol       Date:  1989-08       Impact factor: 4.335

9.  Influence of naloxone on the postoperative analgesic and respiratory effects of buprenorphine.

Authors:  K A Lehmann; U Reichling; R Wirtz
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

10.  Sublingual buprenorphine used postoperatively: clinical observations and preliminary pharmacokinetic analysis.

Authors:  R E Bullingham; H J McQuay; D Dwyer; M C Allen; R A Moore
Journal:  Br J Clin Pharmacol       Date:  1981-08       Impact factor: 4.335

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.